0001610717-23-000390.txt : 20231208
0001610717-23-000390.hdr.sgml : 20231208
20231208160543
ACCESSION NUMBER: 0001610717-23-000390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231206
FILED AS OF DATE: 20231208
DATE AS OF CHANGE: 20231208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grais Linda
CENTRAL INDEX KEY: 0001413306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 231475415
MAIL ADDRESS:
STREET 1: 86 ALEJANDRA AVE
CITY: ATHERTON
STATE: CA
ZIP: 94027
FORMER NAME:
FORMER CONFORMED NAME: Grais Linda S
DATE OF NAME CHANGE: 20070924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
form4.xml
X0508
4
2023-12-06
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001413306
Grais Linda
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
true
false
Stock Option (Right to Buy)
1.64
2023-12-06
4
A
0
15000
0
A
2033-12-06
Common Stock
15000
15000
D
The underlying shares subject to the option vest and become exercisable as to one-twelfth (1/12th) of the shares subject to the option in successive, equal monthly installments measured from December 6, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Linda S. Grais
2023-12-08